- Home
- MMA vs SABS Comparison
MMA vs SABS Comparison
Compare MMA & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- SABS
- Stock Information
- Founded
- MMA 2013
- SABS 2014
- Country
- MMA Australia
- SABS United States
- Employees
- MMA N/A
- SABS N/A
- Industry
- MMA
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- SABS Health Care
- Exchange
- MMA Nasdaq
- SABS Nasdaq
- Market Cap
- MMA 16.3M
- SABS 15.8M
- IPO Year
- MMA 2024
- SABS N/A
- Fundamental
- Price
- MMA $1.33
- SABS $2.64
- Analyst Decision
- MMA
- SABS Strong Buy
- Analyst Count
- MMA 0
- SABS 5
- Target Price
- MMA N/A
- SABS $11.80
- AVG Volume (30 Days)
- MMA 757.5K
- SABS 35.3K
- Earning Date
- MMA 01-21-2025
- SABS 08-07-2025
- Dividend Yield
- MMA N/A
- SABS N/A
- EPS Growth
- MMA N/A
- SABS N/A
- EPS
- MMA N/A
- SABS N/A
- Revenue
- MMA $407,412.00
- SABS $377,835.00
- Revenue This Year
- MMA N/A
- SABS N/A
- Revenue Next Year
- MMA N/A
- SABS N/A
- P/E Ratio
- MMA N/A
- SABS N/A
- Revenue Growth
- MMA N/A
- SABS N/A
- 52 Week Low
- MMA $0.60
- SABS $1.00
- 52 Week High
- MMA $4.11
- SABS $5.01
- Technical
- Relative Strength Index (RSI)
- MMA N/A
- SABS 77.22
- Support Level
- MMA N/A
- SABS $1.72
- Resistance Level
- MMA N/A
- SABS $2.72
- Average True Range (ATR)
- MMA 0.00
- SABS 0.19
- MACD
- MMA 0.00
- SABS 0.10
- Stochastic Oscillator
- MMA 0.00
- SABS 91.89
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.